Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Completed NCT05743361

Security Efficacy COVID-19 Vaccination

Conditions: Autoimmune State, SARS-CoV-2 Infection

Sex: All

Ages: 18 Years – N/A

Healthy volunteers: 1

Enrollment: 540

Sponsor: Istituto Auxologico Italiano

Location: Italy

Summary

Preliminary data support a possible molecular mimicry between SARS-CoV-2 and autologous components. This suggests the occurrence of autoimmunity during COVID-19. Consistently, autoimmunity may occur after SARS-CoV2 vaccination. The study aims to investigate the production of autoantibodies after vaccination in healtcare workers.

Eligibility Criteria

Inclusion Criteria:Healthcare workers undergoing SARS-CoV-2 vaccinationExclusion Criteria:PregnancyFull blown autoimmune diseasesActive vaccinations within 3 months before enrolment (excluding the influenza vaccine)Previous vaccination severe side effects

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05743361). StuddyBuddy aggregates publicly available trial information.